Now live: Pro — the full 13F research suite for serious investorsSee pricing →
SB INVESTMENT ADVISERS (UK) LTD

Q1 2024 · 13F-HR

SB INVESTMENT ADVISERS (UK) LTDholdings as filed

Filed 2024-05-15 · accession 0001493152-24-019427

$10.13B
Reported value
13
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
22266T109CPNGCOUPANG INC$6.22B61.4%349,542,259CommonSOLE
G4124C109GRABGRAB HOLDINGS LIMITED$1.32B13.0%419,633,958CommonSOLE
25809K105DASHDOORDASH INC$842.6M8.32%6,117,955CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$769.8M7.60%73,031,667CommonSOLE
20464U100COMPCOMPASS INC$332.9M3.29%92,470,273CommonSOLE
75943R102RLAYRELAY THERAPEUTICS INC$231.6M2.29%27,904,963CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$169.0M1.67%16,684,041CommonSOLE
051774107AURAURORA INNOVATION INC$111.2M1.10%39,417,358CommonSOLE
35969L108YMMFULL TRUCK ALLIANCE CO LTD$69.9M0.69%9,612,363CommonSOLE
29280W109NRGVENERGY VAULT HOLDINGS INC$33.2M0.33%18,535,631CommonSOLE
37611X100DNA4EURGINKGO BIOWORKS HOLDINGS INC$28.3M0.28%24,429,191CommonSOLE
37427G101GETRGETAROUND INC$6.6M0.07%21,516,384CommonSOLE
92671V304VIEW INC$1.3M0.01%1,103,235CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.